CDKL2 and neoplasm: Among the 151 tumor and nontumor pairs, 68 GC tissues (45.0%) showed low CDKL2 levels (scores of 0 or 1) and 89 nontumor tissues (58.9%) showed high CDKL2 levels (scores of 2 or 3).